In the June issue of Nature Reviews Drug Discovery Aaron Kesselheim and Jerry Avorn from Harvard Medical School in Boston, Massachusetts, published the results of their survey among physicians for the most transformative drugs of the past 25 years (Kesselheim und Avorn, Nat Rev Drug Discov 2013, 12: 425-431). Continue reading
I have not yet covered the antipsychotics in my reporting on the drug prescription report, I want to catch this today. This important group of drugs is discussed in the chapter “psychotropic drugs”. As mentioned already in my post from November 9th, 2012, the quality of the chapter suffers greatly from the superficial and unscientific representation of the two authors Lohse and Müller-Oerlinghausen. I will essentially limit this post on the discussion of the numbers rather than discuss the limitations of the chapter again. Continue reading
This post is currently not available in English, because it is related exclusively to the German drug market.